MeiraGTx Holdings (MGTX) Times Interest Earned (2017 - 2025)
MeiraGTx Holdings posted quarterly Times Interest Earned of $8.67 for Q4 2025, up 193.86% year-on-year from $2.95 in Q4 2024, and up 157.67% on a QoQ basis from -$15.02 in Q3 2025.
MeiraGTx Holdings (MGTX) has 9 years of Times Interest Earned data on file, last reported at $8.67 in Q4 2025.
- For the quarter ending Q4 2025, Times Interest Earned rose 193.86% year-over-year to $8.67; the trailing twelve-month figure through Dec 2025 stood at -$8.69 (up 29.78% YoY), and the FY2025 full-year result was -$8.69, up 29.78% from the prior year.
- Times Interest Earned for Q4 2025 stood at $8.67, up from -$15.02 in the prior quarter.
- Across five years, Times Interest Earned topped out at $8.67 in Q4 2025 and bottomed at -$401.63 in Q2 2021.
- The 5-year median for Times Interest Earned is -$14.14 (2022), against an average of -$101.84.
- The widest annual swing landed in 2024, when Times Interest Earned sank 64.44%; it then jumped 193.86% in 2025.
- A 5-year view of Times Interest Earned shows it stood at -$64.62 in 2021, then jumped by 78.05% to -$14.18 in 2022, then rose by 10.54% to -$12.69 in 2023, then grew by 27.23% to -$9.23 in 2024, then jumped by 193.86% to $8.67 in 2025.
- The last three Times Interest Earned figures came in at $8.67 (Q4 2025), -$15.02 (Q3 2025), and -$14.76 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -129.79 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 3.58 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -258.33 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 11.50 |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 49.84 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 3.88 |
| 10 | MeiraGTx Holdings | 856.58 Mn | 790.65 Mn | 74.89 Mn | 8.67 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 8.67 |
| Sep 30, 2025 | -15.02 |
| Jun 30, 2025 | -14.76 |
| Mar 31, 2025 | -13.67 |
| Dec 31, 2024 | -9.23 |
| Sep 30, 2024 | -11.93 |
| Jun 30, 2024 | -14.11 |
| Mar 31, 2024 | -14.39 |
| Dec 31, 2023 | -12.69 |
| Sep 30, 2023 | -9.69 |
| Jun 30, 2023 | -8.58 |
| Mar 31, 2023 | -10.38 |
| Dec 31, 2022 | -14.18 |
| Sep 30, 2022 | -12.05 |
| Jun 30, 2022 | -289.73 |
| Mar 31, 2022 | -373.17 |
| Dec 31, 2021 | -64.62 |
| Sep 30, 2021 | -382.24 |
| Jun 30, 2021 | -401.63 |
| Mar 31, 2021 | -373.42 |
| Dec 31, 2020 | -367.17 |
| Sep 30, 2020 | -240.86 |
| Jun 30, 2020 | -741.91 |
| Mar 31, 2020 | -461.15 |
| Dec 31, 2019 | -268.13 |
| Sep 30, 2019 | -1,174.91 |
| Jun 30, 2019 | -2,245.32 |
| Mar 31, 2019 | -2,161.14 |
| Dec 31, 2018 | 1,533.09 |
| Sep 30, 2018 | -1,550.09 |
| Jun 30, 2018 | -2,592.58 |
| Mar 31, 2018 | -659.82 |
| Dec 31, 2017 | -195.11 |
| Sep 30, 2017 | -120.47 |
| Jun 30, 2017 | -149.04 |